News release 2021 Covis Pharma Group Announces Two Executive Management Team Appointments December 7, 2021 Covis Significantly Strengthens Global Respiratory Portfolio Through Acquisition of Two Medicines from AstraZeneca November 1, 2021 New data in the European Heart Journal show ciraparantag reverses the anticoagulant activity of apixaban and rivaroxaban in elderly patients October 4, 2021 Covis Pharma Announces FDA’s Decision to Grant Public Hearing for Only FDA-Approved Treatment to Reduce Preterm Birth in Indicated Patients August 19, 2021 COVIS PHARMA GROUP Announces Top-line Safety and Efficacy Data from a Phase 3 Placebo Controlled COVID-19 Study Using Inhaled Corticosteroid (ciclesonide) April 15, 2021 EPPPIC Study Reaffirms 17-OHPC for Reducing Early Preterm Birth in High-Risk, Singleton Pregnancies March 26, 2021 News release Contact Us 2023 2022 2021 2020 2018 2017 2015 2013
Covis Significantly Strengthens Global Respiratory Portfolio Through Acquisition of Two Medicines from AstraZeneca November 1, 2021
New data in the European Heart Journal show ciraparantag reverses the anticoagulant activity of apixaban and rivaroxaban in elderly patients October 4, 2021
Covis Pharma Announces FDA’s Decision to Grant Public Hearing for Only FDA-Approved Treatment to Reduce Preterm Birth in Indicated Patients August 19, 2021
COVIS PHARMA GROUP Announces Top-line Safety and Efficacy Data from a Phase 3 Placebo Controlled COVID-19 Study Using Inhaled Corticosteroid (ciclesonide) April 15, 2021
EPPPIC Study Reaffirms 17-OHPC for Reducing Early Preterm Birth in High-Risk, Singleton Pregnancies March 26, 2021